Moreover, we demonstrated that tumor ETV4 expression influences the crosstalk with infiltrating immune cells within the melanoma TME and affects the response to anti-PD-1 therapy, potentially due to its role in transcriptionally activating CD274 expression. The gene discussed is CD274; the disease is neoplasm.